Advertisement

Lasers in Medical Science

, Volume 29, Issue 1, pp 137–140 | Cite as

Telangiectasis in CREST syndrome and systemic sclerosis: correlation of clinical and pathological features with response to pulsed dye laser treatment

  • Shlomit HalachmiEmail author
  • Osama Gabari
  • Sarit Cohen
  • Romelia Koren
  • Dan Ben Amitai
  • Moshe Lapidoth
Original Article

Abstract

Telangiectasia are cardinal features of systemic sclerosis (SS) and calcinosis, Raynaud’s syndrome, esophageal motility, sclerodactyly, telangiectasias (CREST) syndrome. The etiology of telangiectasia in these syndromes is unknown, but vascular dysfunction has been proposed. However, the telangiectasia of CREST have anecdotally been considered relatively resistant to pulse dye laser (PDL), the treatment of choice for classic telangiectasia. The study was designed to test whether SS/CREST telangiectasia require more treatments than sporadic telangiectasia and to identify clinical and histological features that could explain such an effect. Nineteen skin biopsies from patients with SS or CREST and 10 control biopsies were examined and compared for features that may predict a differential response to PDL. Sixteen cases of SS or CREST treated with PDL between 1997 and 2007 were evaluated and response to treatment was compared with 20 patients with sporadic telangiectasis. Relative to normal skin, CREST/scleroderma telangiectasia exhibited thickened vessels in 17 out of 19 sections and thickened collagen fibers in the reticular or deep dermis in all sections. The number of treatments required to clear SS/CREST telangiectasia was approximately twofold higher. SS/CREST telangiectasia are more resistant to PDL but can be effectively cleared with more treatments.

Keywords

CREST Telangiectasia Pulsed dye laser Vascular laser Scleroderma 

References

  1. 1.
    Meyer O (1999) [From Thibierge–Weissenbach syndrome (1910) to anti-centromere antibodies (1980). Clinical and biological features of scleroderma]. Ann Med Interne (Paris) 150:47–52Google Scholar
  2. 2.
    Winterbauer RH (1964) Multiple telangiectasia, Raynaud’s phenomenon, sclerodactyly, and subcutanious calcinosis: a syndrome mimicking hereditary hemorrhagic telangiectasia. Bull Johns Hopkins Hosp 114:361–383PubMedGoogle Scholar
  3. 3.
    Frayha RA, Scarola JA, Shulman LE (1973) Calcinosis in scleroderma: a reevaluation of the CRST syndrome, abstracted. Arthritis Rheum 16:542Google Scholar
  4. 4.
    Velayos EE, Masi AT, Stevens MB, Shulman LE (1979) The 'CREST' syndrome. Comparison with systemic sclerosis (scleroderma). Arch Intern Med 139:1240–1244PubMedCrossRefGoogle Scholar
  5. 5.
    Rouquette-Gally AM, Stern MH, Prost AC, Abuaf N, Homberg JC, Combrisson A (1985) Anti-centromere antibody, biological marker of the CREST syndrome as distinct from scleroderma. Presse Med 14:1497–1500PubMedGoogle Scholar
  6. 6.
    Cafagna D, Melon F, Balbi M, Ponte E (1998) Vascular manifestations in systemic sclerosis (scleroderma). Minerva Med 89:153–161PubMedGoogle Scholar
  7. 7.
    Freemont AJ, Hoyland J, Fielding P, Hodson N, Jayson MI (1992) Studies of the microvascular endothelium in uninvolved skin of patients with systemic sclerosis: direct evidence for a generalized microangiopathy. Br J Dermatol 126:561–568PubMedCrossRefGoogle Scholar
  8. 8.
    Chizzolini C, Parel Y, Scheja A, Dayer JM (2006) Polarized subsets of human T-helper cells induce distinct patterns of chemokine production by normal and systemic sclerosis dermal fibroblasts. Arthritis Res Ther 8:R10PubMedCentralPubMedCrossRefGoogle Scholar
  9. 9.
    Oliver SJ (2000) The Th1/Th2 paradigm in the pathogenesis of scleroderma, and its modulation by thalidomide. Curr Rheumatol Rep 2:486–491PubMedCrossRefGoogle Scholar
  10. 10.
    Walker JG, Stirling J, Beroukas D, Dharmapatni K, Haynes DR, Smith MD et al (2005) Histopathological and ultrastructural features of dermal telangiectasias in systemic sclerosis. Pathology 37:220–225PubMedCrossRefGoogle Scholar
  11. 11.
    Braverman IM (1989) Ultrastructure and organization of the cutaneous microvasculature in normal and pathologic states. J Invest Dermatol 93:2S–9SPubMedCrossRefGoogle Scholar
  12. 12.
    Anderson RR, Parrish JA (1983) Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science 220:524–527PubMedCrossRefGoogle Scholar
  13. 13.
    Polla LL, Tan OT, Garden JM, Parrish JA (1987) Tunable pulsed dye laser for the treatment of benign cutaneous vascular ectasia. Dermatologica 174:11–17PubMedCrossRefGoogle Scholar
  14. 14.
    Eisen D, Alster TS (2002) Use of a 585 nm pulsed dye laser for the treatment of morphea. Dermatol Surg 28:615–616PubMedCrossRefGoogle Scholar
  15. 15.
    Ciatti S, Varga J, Greenbaum SS (1996) The 585 nm flashlamp-pumped pulsed dye laser for the treatment of telangiectases in patients with scleroderma. J Am Acad Dermatol 35:487–488PubMedCrossRefGoogle Scholar
  16. 16.
    Braverman IM, Ken-Yen A (1983) Ultrastructure and three-dimensional reconstruction of several macular and papular telangiectases. J Invest Dermatol 81:489–497PubMedCrossRefGoogle Scholar
  17. 17.
    Anderson RR, Parrish JA (1981) Microvasculature can be selectively damaged using dye lasers: a basic theory and experimental evidence in human skin. Lasers Surg Med 1:263–276PubMedCrossRefGoogle Scholar
  18. 18.
    Garden JM, Tan OT, Kerschmann R, Boll J, Furumoto H, Anderson RR et al (1986) Effect of dye laser pulse duration on selective cutaneous vascular injury. J Invest Dermatol 87:653–657PubMedCrossRefGoogle Scholar
  19. 19.
    Paul BS, Anderson RR, Jarve J, Parrish JA (1983) The effect of temperature and other factors on selective microvascular damage caused by pulsed dye laser. J Invest Dermatol 81:333–336PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London 2013

Authors and Affiliations

  • Shlomit Halachmi
    • 1
    Email author
  • Osama Gabari
    • 1
  • Sarit Cohen
    • 1
  • Romelia Koren
    • 2
    • 3
  • Dan Ben Amitai
    • 3
    • 4
  • Moshe Lapidoth
    • 1
    • 3
  1. 1.Laser Unit, Department of DermatologyRabin Medical CenterPetach TikvaIsrael
  2. 2.Department of PathologyRabin Medical CenterPetach TikvaIsrael
  3. 3.Sackler School of MedicineTel Aviv UniversityTel AvivIsrael
  4. 4.Department of DermatologySchneider Childern’s HospitalPetach TikvaIsrael

Personalised recommendations